Research report published by Markets N Research “Immunoassay, By Type (Enzyme Immunoassay (EIA), Radioimmunoassay (RIA), Fluoroimmunoassay (FIA), Chemiluminescent Immunoassay (CLIA) and Counting Immunoassay (CIA)); By Application (Infectious Diseases, Oncology, Blood Screening, Cardiology and Others) Market - Growth, Future Prospects, Post COVID-19 Scenario 2020 – 2028”,states that the global Immunoassay is expected to grow at a CAGR of 6.8% during the forecast period from 2021 to 2028.
Rising prevalence of various chronic diseases and need for their diagnosis as early as possible is prevailing the requirement of immunoassays test. Increasing instances of cancer is elevating the need for an individual to test for preventing further damage in the body. Also, Immunoassays are being highly used to detect COVID-19 as well as other infectious diseases which are on the rise and hence in order to control the spread of virus these tests along with many other are carried out. Thereby these factors are expected to increase the growth as well as the disposable income of the market globally.
Several applications of immunoassay include infectious diseases, oncology, blood screening, cardiology, etc. Among the applications, infectious diseases held the largest market share in past years owing to prevailing covid-19 globally and other infectious diseases which remain undiagnosed, eventually growing the demand of immunoassays.
Leading companies operating in the immunoassay manufacturing are working towards improving the quality of tests so that the tests can be carried out in minimum time. Some of the prominent players of the market include Danaher Corp., Thermo Fisher Scientific company, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Quidel Corporation., DiaSorin S.p.A, bioMérieux SA, Bio-Rad Laboratories, Inc. and Ortho-Clinical Diagnostics, Inc.
Trends and Future Outlook:
Rising prevalence of various chronic diseases and need for their diagnosis as early as possible is prevailing the requirement of immunoassays test. Increasing instances of cancer is elevating the need for an individual to test for preventing further damage in the body. Also, Immunoassays are being highly used to detect COVID-19 as well as other infectious diseases which are on the rise and hence in order to control the spread of virus these tests along with many other are carried out. Thereby these factors are expected to increase the growth as well as the disposable income of the market globally.
Several applications of immunoassay include infectious diseases, oncology, blood screening, cardiology, etc. Among the applications, infectious diseases held the largest market share in past years owing to prevailing covid-19 globally and other infectious diseases which remain undiagnosed, eventually growing the demand of immunoassays.
Leading companies operating in the immunoassay manufacturing are working towards improving the quality of tests so that the tests can be carried out in minimum time. Some of the prominent players of the market include Danaher Corp., Thermo Fisher Scientific company, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Quidel Corporation., DiaSorin S.p.A, bioMérieux SA, Bio-Rad Laboratories, Inc. and Ortho-Clinical Diagnostics, Inc.
Trends and Future Outlook:
- Creative Diagnostics has developed new immunoassay kit that is designed specifically to detect corona virus as well as the antibodies that can fight against COVID-19.
